Rob Koremans
2017
In 2017, Rob Koremans earned a total compensation of $5.1M as Former President and CEO, Global Specialty at Teva Pharmaceutical Industries.
Compensation breakdown
| Option Awards | $833,361 |
|---|---|
| Salary | $783,215 |
| Stock Awards | $1,666,644 |
| Other | $1,807,975 |
| Total | $5,091,195 |
Koremans received $1.8M in other compensation, accounting for 36% of the total pay in 2017.
Koremans also received $833.4K in option awards, $783.2K in salary and $1.7M in stock awards.
Rankings
In 2017, Rob Koremans' compensation ranked 1,837th out of 14,666 executives tracked by ExecPay. In other words, Koremans earned more than 87.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,837 out of 14,666 | 88th |
Division Manufacturing | 613 out of 5,768 | 89th |
Major group Chemicals And Allied Products | 163 out of 2,074 | 92nd |
Industry group Drugs | 118 out of 1,730 | 93rd |
Industry Pharmaceutical Preparations | 91 out of 1,329 | 93rd |
Source: SEC filing on April 25, 2018.
Koremans' colleagues
We found nine more compensation records of executives who worked with Rob Koremans at Teva Pharmaceutical Industries in 2017.
2017
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Yitzhak Peterburg
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Carlo de Notaristefani
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2017
Michael Hayden
Teva Pharmaceutical Industries
Chief Scientific Officer
2017
Eyal Desheh
Teva Pharmaceutical Industries
Chief Financial Officer
2017
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2017
Erez Vigodman
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Mark Sabag
Teva Pharmaceutical Industries
Executive Vice President, Global Human Resources
2017
Michael McClellan
Teva Pharmaceutical Industries